Surgical management of gastroesophageal reflux disease in the obese patient.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
01 2020
Historique:
received: 20 10 2019
accepted: 28 10 2019
pubmed: 14 11 2019
medline: 21 10 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

Gastroesophageal reflux disease (GERD) affects two thirds of the American population. Obesity is also a disease that affects two thirds of the population. The pathophysiology of reflux disease is reasonably understood, however, the degree to which obesity affects this disease remains poorly defined. Therefore the approach to GERD in the obese patient requires special attention and its own algorithm. A literature search was conducted to consolidate the current available literature on GERD and its management in the obese. In addition, the authors reviewed the literature and present expert opinion on controversial topics. It is well established that GERD is increased in obesity and the pathophysiology is reviewed. Management options for GERD are discussed, with a focus on the obese population. Management strategies including fundoplication and gastric bypass are discussed. In addition, bariatric surgery in the setting of GERD is also reviewed. Currently this is an extremely controversial topic and this white paper presents a strong review of the literature to help guide the management of this challenging disease in this population. Expert recommendations are given throughout the paper based upon the current available data.

Sections du résumé

BACKGROUND
Gastroesophageal reflux disease (GERD) affects two thirds of the American population. Obesity is also a disease that affects two thirds of the population. The pathophysiology of reflux disease is reasonably understood, however, the degree to which obesity affects this disease remains poorly defined. Therefore the approach to GERD in the obese patient requires special attention and its own algorithm.
METHODS
A literature search was conducted to consolidate the current available literature on GERD and its management in the obese. In addition, the authors reviewed the literature and present expert opinion on controversial topics.
RESULTS
It is well established that GERD is increased in obesity and the pathophysiology is reviewed. Management options for GERD are discussed, with a focus on the obese population. Management strategies including fundoplication and gastric bypass are discussed. In addition, bariatric surgery in the setting of GERD is also reviewed.
CONCLUSIONS
Currently this is an extremely controversial topic and this white paper presents a strong review of the literature to help guide the management of this challenging disease in this population. Expert recommendations are given throughout the paper based upon the current available data.

Identifiants

pubmed: 31720811
doi: 10.1007/s00464-019-07231-w
pii: 10.1007/s00464-019-07231-w
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

450-457

Références

JAMA. 2018 Jan 16;319(3):255-265
pubmed: 29340679
Rom J Gastroenterol. 2005 Jun;14(2):117-21
pubmed: 15990929
Surgery. 2016 Feb;159(2):475-86
pubmed: 26054318
World J Gastroenterol. 2017 Apr 7;23(13):2269-2275
pubmed: 28428706
N Engl J Med. 2006 Jun 1;354(22):2340-8
pubmed: 16738270
J Am Coll Surg. 2011 Oct;213(4):461-8
pubmed: 21715189
J Gastrointest Surg. 2009 Aug;13(8):1440-7
pubmed: 19475461
Am J Gastroenterol. 1999 Oct;94(10):2840-4
pubmed: 10520831
Rev Gastroenterol Disord. 2008 Fall;8(4):233-9
pubmed: 19107097
Ann Surg. 2016 Jan;263(1):110-6
pubmed: 25607766
JAMA Surg. 2014 Apr;149(4):328-34
pubmed: 24500799
Am Surg. 2005 Nov;71(11):950-3; discussion 953-4
pubmed: 16372614
Obes Surg. 2014 Sep;24(9):1436-41
pubmed: 24619293
Surg Endosc. 2010 Nov;24(11):2647-69
pubmed: 20725747
J Clin Gastroenterol. 2017 Feb;51(2):91-99
pubmed: 28005634
Obes Surg. 2012 Dec;22(12):1874-9
pubmed: 22915063
Surg Endosc. 2012 Jan;26(1):177-81
pubmed: 21858578
World J Gastroenterol. 2010 Aug 14;16(30):3757-61
pubmed: 20698037
Am J Gastroenterol. 2009 Mar;104(3):553-9
pubmed: 19223881
Obes Surg. 2015 May;25(5):763-8
pubmed: 25411120
Surg Obes Relat Dis. 2017 Apr;13(4):568-574
pubmed: 28089434
Am J Surg. 2016 Jan;211(1):250-67
pubmed: 26341463
Eur J Gastroenterol Hepatol. 2006 Apr;18(4):369-74
pubmed: 16538107
Surg Endosc. 2001 Sep;15(9):986-9
pubmed: 11443428
World J Gastroenterol. 2015 Sep 28;21(36):10348-57
pubmed: 26420961
Surg Obes Relat Dis. 2009 Mar-Apr;5(2):139-43
pubmed: 18996768
Am J Surg. 2016 Mar;211(3):571-6
pubmed: 26785802
Scand J Gastroenterol. 1988 May;23(4):427-32
pubmed: 3381064
JAMA. 2001 May 9;285(18):2331-8
pubmed: 11343480
Surg Endosc. 2002 Jul;16(7):1027-31
pubmed: 11984683
Clin Gastroenterol Hepatol. 2005 Jun;3(6):543-52
pubmed: 15952096
Ann Surg. 2013 Dec;258(6):976-82
pubmed: 23160151
Obes Surg. 2002 Oct;12(5):634-8
pubmed: 12448383
Surg Obes Relat Dis. 2007 Jan-Feb;3(1):52-7; discussion 58-9
pubmed: 17116426
Obes Surg. 2004 Nov-Dec;14(10):1373-80
pubmed: 15603654
Obes Surg. 2018 Jun;28(6):1731-1737
pubmed: 29313277
J Obes. 2017;2017:7589408
pubmed: 28584666
Surg Endosc. 2010 Aug;24(8):1996-2001
pubmed: 20135170
Obes Surg. 2010 Mar;20(3):357-62
pubmed: 20013071
Obes Surg. 2010 Feb;20(2):140-7
pubmed: 19949885
Aliment Pharmacol Ther. 2003 Oct 15;18(8):767-76
pubmed: 14535869
Arq Bras Cir Dig. 2017 Jul-Sep;30(3):216-221
pubmed: 29019565
Obes Surg. 2008 Oct;18(10):1217-24
pubmed: 18512110
J Health Econ. 2012 Jan;31(1):219-30
pubmed: 22094013
J Neurogastroenterol Motil. 2013 Jul;19(3):338-43
pubmed: 23875101
Ann Intern Med. 2005 Aug 2;143(3):199-211
pubmed: 16061918
J Gastrointest Surg. 2007 Mar;11(3):286-90
pubmed: 17458599
Obes Surg. 2017 Dec;27(12):3092-3101
pubmed: 28593484
Obes Surg. 2014 Jan;24(1):71-7
pubmed: 24249251
Surg Endosc. 2014 May;28(5):1500-4
pubmed: 24310740
J Gastrointest Surg. 2015 Jan;19(1):111-5; discussion 115-6
pubmed: 25213580
Surg Endosc. 2019 Jun 25;:null
pubmed: 31240476
Surg Endosc. 2003 Oct;17(10):1561-5
pubmed: 12874685
Surg Obes Relat Dis. 2017 May;13(5):742-749
pubmed: 28416400
Obes Surg. 2015 Jan;25(1):159-66
pubmed: 25348434
Am J Gastroenterol. 2005 Jun;100(6):1243-50
pubmed: 15929752
Surg Obes Relat Dis. 2017 Feb;13(2):138-142
pubmed: 27639982
NCHS Data Brief. 2017 Oct;(288):1-8
pubmed: 29155689
Surg Endosc. 2007 Nov;21(11):1978-84
pubmed: 17623236
Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329
pubmed: 23419381
Int J Epidemiol. 2012 Dec;41(6):1706-18
pubmed: 23148106
Obes Surg. 1997 Feb;7(1):16-8
pubmed: 9730531
Gastroenterology. 2007 Mar;132(3):883-9
pubmed: 17324403
Clin Gastroenterol Hepatol. 2007 Jan;5(1):17-26
pubmed: 17142109
Surg Obes Relat Dis. 2017 Dec;13(12):1945-1950
pubmed: 28964697
Surg Obes Relat Dis. 2018 Jun;14(6):757-762
pubmed: 29477376
Ann Surg. 2014 Nov;260(5):909-14; discussion 914-5
pubmed: 25379861
Dig Dis Sci. 2008 Sep;53(9):2307-12
pubmed: 18651221

Auteurs

P Nau (P)

Department of Surgery, Carver College of Medicine, Iowa City, IA, USA.

H T Jackson (HT)

George Washington School of Medicine and Life Sciences, Washington, DC, USA.

A Aryaie (A)

Department of Surgery, Texas Tech, Lubbock, TX, USA.

A Ibele (A)

University of Utah College of Medicine, Salt Lake City, UT, USA.

D Shouhed (D)

Department of Surgery, Cedars Sinai Medical Center, Los Angeles, CA, USA.

E Lo Menzo (E)

Department of Surgery, Cleveland Clinic Florida, Weston, FL, USA.

M Kurian (M)

New York University School of Medicine, New York, NY, USA.

L Khaitan (L)

Cleveland Medical Center, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH, 44106, USA. Leena.Khaitan@UHhospitals.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH